Flora pro.activ: A clinical and financial impact analysis

Journal of Medical Economics

Volumn 3, Issue 61-76, 2000, Pages 61-76

  Phillips, C ^a   Belsey, J ^a   Shindler, J ^a  

^a JB Medical Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPESTEROL; CHOLESTEROL; FLORA PRO ACTIV; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN; MARGARINE; PHYTOSTEROL; SITOSTEROL;

BEHAVIOR MODIFICATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST CONTROL; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LOW FAT DIET; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; POPULATION RISK; REVIEW; SMALL INTESTINE ABSORPTION; TREATMENT OUTCOME;

EID: 0033765359     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Prevention of coronary heart disease in clinical practice
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
3. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
5. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
6. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
7. A scoring system to identify men at high risk of heart attack
8. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 Years of follow-up in the Framingham study
9. British Regional Heart Study: Cardiovascular risk factors in middle-aged men in 24 towns
10. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial
11. Nutritional aspects of cardiovascular disease
12. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
13. Can dietary interventions change diet and cardiovascular risk factors? A meta-analysis of randomised controlled trials
14. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease
15. Dietary phytosterols: A review of metabolism, benefits and side effects
16. Lowering serum cholesterol with plant sterols and stanols. Historical perspectives
17. Effects of plant sterols on serum lipids and atherosclerosis
18. Spreads enriched with plant sterols, either esterified 4,4-dimethylsterols or free 4-desmethylsterols, and plasma total- and LDL-cholesterol concentrations
19. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects
20. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects
21. Randomised controlled trial of use of a vegetable oil sterol-enriched fat spread by hypercholesterolaemic patients
22. New lipid-lowering drugs and new effects of old drugs
23. Plant sterol and stanol margarines and health
24. Metabolism of beta-sitosterol in man
25. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters
26. Cardiovascular disease risk profiles
27. A simple computer programme for guiding management of cardiovascular risk factors and prescribing
28. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease
29. The cost-effectiveness of hypertension treatment in Sweden: An analysis of the criteria for intervention and the choice of drug treatment
30. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
31. Myocardial infarction and coronary deaths in the World Health Organisation MONICA project
32. Coronary event and case fatality rates in an English population: Results of the Oxford myocardial infarction incidence study
33. Outcome and use of health services four years after admission for acute myocardial infarction: Case record follow up study
34. National Schedule of Reference Costs
35. Prevalence of coronary heart disease within a population of 901 829 sampled in the United Kingdom and level of secondary prevention of coronary heart disease among those identified
36. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolemia (the Curves study)
37. Lipid-lowering for prevention of coronary heart disease: What policy now?